Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Parasitologic Impact of Different Mass Drug Administration Strategies Against Schistosoma Mansoni in Endemic Areas of Mwanza Region, Tanzania, Where Prevalence is 25% or Above

NCT02162875 is registered in ClinicalTrials.gov with DBL -Institute for Health Research and Development as lead sponsor.

NCT NCT02162875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02162875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Parasitologic Impact of Different Mass Drug Administration Strategies Against Schistosoma Mansoni in Endemic Areas of Mwanza Region, Tanzania, Where Prevalence is 25% or Above
Lead sponsor
DBL -Institute for Health Research and Development
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2011
Completion date
January 31, 2017
Enrollment
37,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schistosoma mansoni